(LLY) Eli Lilly - Performance 15.8% in 12m
Compare LLY with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
71.00%
#7 in Group
Rel. Strength
70.56%
#2350 in Universe
Total Return 12m
15.84%
#44 in Group
Total Return 5y
523.45%
#4 in Group
P/E 75.7
94th Percentile in Group
P/E Forward 38.9
80th Percentile in Group
PEG 1.41
67th Percentile in Group
FCF Yield 0.15%
43th Percentile in Group
12m Total Return: LLY (15.8%) vs XLV (1.7%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: LLY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for LLY
Total Return (including Dividends) | LLY | XLV | S&P 500 |
---|---|---|---|
1 Month | 8.84% | -3.79% | -0.87% |
3 Months | 11.02% | -3.99% | -7.58% |
12 Months | 15.84% | 1.72% | 11.88% |
5 Years | 523.45% | 55.40% | 110.33% |
Trend Score (consistency of price movement) | LLY | XLV | S&P 500 |
1 Month | 71.4% | -3.2% | 23% |
3 Months | -32.3% | -71.4% | -88.5% |
12 Months | -18.3% | -17.5% | 55.1% |
5 Years | 98.0% | 89.8% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #48 | 13.1% | 9.80% |
3 Month | #27 | 15.6% | 20.1% |
12 Month | #45 | 13.9% | 3.54% |
5 Years | #3 | 301% | 196% |
FAQs
Does LLY Eli Lilly outperforms the market?
Yes,
over the last 12 months LLY made 15.84%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months LLY made 11.02%, while XLV made -3.99%.
Over the last 3 months LLY made 11.02%, while XLV made -3.99%.
Performance Comparison LLY vs Indeces and Sectors
LLY vs. Indices LLY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.81% | 9.71% | 10.6% | 3.96% |
US NASDAQ 100 | QQQ | 3.78% | 7.44% | 10.1% | 3.17% |
US Dow Jones Industrial 30 | DIA | 5.75% | 12.0% | 10.7% | 6.64% |
German DAX 40 | DAX | 6.04% | 7.52% | -8.95% | -8.84% |
Shanghai Shenzhen CSI 300 | CSI 300 | 8.77% | 11.7% | 13.6% | 9.88% |
Hongkong Hang Seng | HSI | 5.80% | 8.78% | 8.65% | 1.95% |
India NIFTY 50 | INDA | 7.65% | 4.78% | 10.3% | 12.8% |
Brasil Bovespa | EWZ | 5.61% | 4.24% | 6.87% | 21.7% |
LLY vs. Sectors LLY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.56% | 9.89% | 4.44% | -8.12% |
Consumer Discretionary | XLY | 4.73% | 8.94% | 8.06% | 2.52% |
Consumer Staples | XLP | 8.31% | 8.64% | 5.26% | 4.64% |
Energy | XLE | 9.29% | 22.7% | 16.4% | 26.9% |
Financial | XLF | 6.20% | 11.0% | 2.97% | -6.85% |
Health Care | XLV | 4.89% | 12.6% | 12.3% | 14.1% |
Industrial | XLI | 4.39% | 8.73% | 9.86% | 6.25% |
Materials | XLB | 5.42% | 11.3% | 18.0% | 19.4% |
Real Estate | XLRE | 6.33% | 10.2% | 11.5% | -2.25% |
Technology | XLK | 2.36% | 7.15% | 13.9% | 8.11% |
Utilities | XLU | 7.65% | 8.78% | 8.45% | -5.99% |
Aerospace & Defense | XAR | 3.86% | 2.45% | -2.96% | -10.7% |
Biotech | XBI | 3.51% | 6.56% | 23.2% | 17.7% |
Homebuilder | XHB | 5.50% | 11.1% | 25.4% | 22.9% |
Retail | XRT | 6.38% | 9.40% | 16.1% | 18.6% |